P.004 HEALING ABUTMENTS AND CLOSURE SCREWS
K071585 · Straumann USA · NHA · Jul 11, 2007 · Dental
Device Facts
| Record ID | K071585 |
| Device Name | P.004 HEALING ABUTMENTS AND CLOSURE SCREWS |
| Applicant | Straumann USA |
| Product Code | NHA · Dental |
| Decision Date | Jul 11, 2007 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 872.3630 |
| Device Class | Class 2 |
Intended Use
P.004 Healing Abutments and P.004 Closure Screws are intended for use with the Straumann P.004 Bone Level Implant system to protect the inner configuration of the implant and maintain, stabilize and form the soft tissue during the healing process.
Device Story
Device consists of healing abutments and closure screws used with Straumann P.004 Bone Level Implant system. Components protect implant inner configuration; healing abutments additionally maintain, stabilize, and form soft tissue during healing. Used in clinical dental settings by dental professionals. No software or electronic components.
Clinical Evidence
No clinical data; bench testing only.
Technological Characteristics
Endosseous dental implant abutments and closure screws. Mechanical components designed for integration with Straumann P.004 Bone Level Implant system. No software, electronics, or energy sources.
Indications for Use
Indicated for use with the Straumann P.004 Bone Level Implant system in partially or fully edentulous patients requiring dental implants to protect the implant's inner configuration and to maintain, stabilize, and form soft tissue during the healing process.
Regulatory Classification
Identification
An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.
Special Controls
*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
Predicate Devices
- RC Healing Abutments (K062129)
- RC Closure Screws (K062129)
Related Devices
- K072071 — STRAUMANN P.004 CEMENTABLE ABUTMENTS, TEMPORARY COPINGS AND PROTECTIVE CAPS · Institut Straumann AG · Aug 15, 2007
- K091701 — STRAUMANN MODIFIED DENTAL ABUTMENT · Institut Straumann AG · Dec 22, 2009
- K161677 — Straumann Sterile Healing Solution · Institut Straumann AG · Oct 7, 2016
- K052957 — IMPLANTIUM PROSTHETICS · Dentium Co., Ltd. · Jul 27, 2006
- K013798 — PROSTHETIC ACCESSORIES TO THE ITI DENTAL IMPLANT SYSTEM · Institut Straumann AG · Dec 19, 2001
Submission Summary (Full Text)
{0}------------------------------------------------
K071585
# Section H 510(k) Summary
JUL 1 1 2007
## 1. Applicant's Name and Address Straumann USA (on behalf of Institut Straumann AG) 60 Minuteman Rd. Andover, MA 01810 Telephone Number: 800-448-8168, ext 2513 Fax Number: 978-747-0023 Contact Person: Elaine Alan Regulatory Affairs Specialist
#### 2. Name of the Device
| Trade Name: | NC Healing Abutments, NC Closure Screws |
|----------------------|-----------------------------------------|
| Common Name: | Abutment, Dental, Endosseous implants |
| Classification Name: | Abutment, Dental, Endosseous implants |
| | §21 CFR 872.3630 |
### 3. Legally Marketed Device to which Equivalence is Claimed (Predicate Device)
P.004 RC Healing Abutments, K062129 P.004 RC Closure Screws, K062129
#### 4. Description of the Device
The Straumann Dental Implant System is an integrated system of endosseous dental implants, which are designed to support prosthetic devices for partially or fully edentulous patients. The system consists of a variety of dental implants, abutments and surgical and prosthetic parts and instruments. The device covered in this submission is healing abutments and closure screws.
Healing abutments and closure screws are used to protect the inner configuration of the implant and to maintain, stabilize and form the soft tissue. Healing Abutments have a secondary function to maintain, stabilize and form the soft tissue during the healing process
#### 5. Intended Use of the Device
P.004 Healing Abutments and P.004 Closure Screws are intended for use with the Straumann P.004 Bone Level Implant system to protect the inner configuration of the implant and maintain, stabilize and form the soft tissue during the healing process.
{1}------------------------------------------------
K891585
202
### 6. Basis for Substantial Equivalence
The modified NC Healing Abutments and Closure Screws are substantially equivalent to the currently marketed RC Healing Abutments and closure screws. The intended use is identical to the predicate devices. The proposed abutments and closure screws have the same material composition, basic design and fundamental operating principles to the currently marketed devices.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo features a stylized depiction of an eagle or bird-like figure with outstretched wings. The bird is black and is positioned to the right of the text. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
# JUL 1 1 2007
Ms. Elaine Alan Regulatory Affairs Specialist Straumann USA (on behalf of Institut Straumann AG) 60 Minuteman Road Andover, Massachusetts 01810
Re: K071585
Trade/Device Name: P.004 Healing Abutments and Closure Screws Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: II Product Code: NHA Dated: June 8, 2007 Received: June 11, 2007
Dear Ms. Alan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 -- Ms. Alan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Clu
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
K071585
Indications for Use Statement
Device Name: P.004 Healing Abutments and Closure Screws
Indications for Use:
P.004 Healing Abutments and Closure Screws are intended for use with the Straumann P.004 Bone Level Implant system to protect the inner configuration of the implant. Healing Abutments have a secondary function to maintain, stabilize and form the soft tissue during the healing process.
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
AND/OR
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
Kira Hulsey for MSR
(Division Sign-Utl) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K07 |5 85
510(k) Submission: P.004 NC Healing Abutments June 8, 2007 Proprietary and Confidential Straumann US Page 5-43